| May 1 |
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial
Operations into Canada |
| May 1 |
Eisai Gained Favourable Ruling by Court of Appeal, as NICE Process
for Developing Guidance on Anti-dementia Medicines Ruled Unfair |
| May 1 |
NUCRYST Announces Management Realignment and R&D Portfolio
Change |
| May 1 |
Abbott, Takeda Conclude TAP Joint Venture |
| May 1 |
SEC Charges McCann-Erickson Worldwide With Accounting Fraud |
| May 1 |
Interpublic Announces Agreement to Settle SEC Claims |
| May 1 |
'Sharing Miracles' Television Program to Feature Leave it to Beaver
Star Jerry Mathers |
| May 1 |
Renovis Stockholders Approve Acquisition by Evotec |
| May 2 |
Roche Exercises its Option to Further Develop and Commercialize
Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 |
| May 2 |
QSV Biologics Awarded cGMP Manufacturing Contract by Pfizer Inc. |
| May 2 |
Merck Extends Enrollment Deadline in Program to Resolve U.S. Vioxx
Product Liability Lawsuits |
| May 2 |
Critical Therapeutics Signs Definitive Agreement to Merge with
Cornerstone BioPharma |
| May 5 |
Nordic Capital Fund VII and Avista Capital Partners Agree to
Acquire ConvaTec Business for approximately $4.1 Billion |
| May 5 |
Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase
II Clinical Trial In Metastatic Colorectal Cancer |
| May 5 |
VaxGen Sells Anthrax Vaccine Program and Related Assets and
Technology to Emergent BioSolutions, Inc. |
| May 5 |
GE Healthcare Signs Global Molecular Diagnostic Agreement to
Advance Respiratory Drug Development |
| May 6 |
Merck to Reduce U.S. Sales Force by 1,200 Positions |
| May 6 |
Bayer Schering Pharma to Market New Low-dose Oral Contraceptive Yaz
in Europe |
| May 6 |
Teva Reports First Quarter 2008 Results |
| May 6 |
EPO Announces Symbicort European COPD Use Patent Decision |
| May 6 |
Fougera First-to-Market With Calcipotriene Topical Solution 0.005%
(Rx) (Scalp Solution) |
| May 6 |
Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development |
| May 7 |
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off
Biotechnology Business |
| May 7 |
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio
Licenses From Bayer Healthcare |
| May 7 |
Quintiles Signs Agreement to Acquire Eidetics |
| May 8 |
King Pharmaceuticals Reports First-Quarter 2008 Financial Results |
| May 8 |
Biovail Announces New Strategic Focus |
| May 8 |
Novartis Exercises Rights to Purchase Additional Shares of
Alnylam's Common Stock in Accordance with Terms of Existing
Investor Rights Agreement |
| May 8 |
GAO Report: Prescription Drugs - Trends in FDA’s Oversight of
Direct-to-Consumer Advertising |
| May 8 |
FDA Sends Letter to Shire Over Fosrenol Promotional Materials |
| May 8 |
FDA Sends Novartis Warning Letter Over Trileptal Promotional
Materials. |
| May 9 |
Orion has decided not to continue the development of a new COMT
inhibitor candidate |
| May 9 |
Schweizerhall: Impending Approval of Clopidogrel from Cimex in
Germany |
| May 9 |
Takeda Sees Operating Profit Drop for 2nd Yr on Swelling Costs |
| May 9 |
Lancet: Combating Counterfeit Drugs |
| May 12 |
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the
Termination of the Azor Co-Promotion Agreement |
| May 12 |
Lilly Completes Final Phase of Its Indianapolis Biotechnology
Complex |
| May 12 |
Walgreens Health Initiatives Reports Negative Drug Trend for Highly
Managed Plans |
| May 13 |
Pharmexa Stops One of Two Phase III Trials |
| May 13 |
Palatin Technologies Announces New Strategic Objectives and Reports
Third Quarter 2008 Financial Results |
| May 13 |
Daiichi Sankyo: Expansion of Business into Turkey and India |
| May 13 |
Lilly Partners With TopCoder, to Find Drug Discovery IT Solutions |
| May 13 |
Higher Risk of Death and Stroke in Patients Given Beta-Blockers After
Non-Cardiac Surgery (POISE Trial) |
| May 13 |
Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance
to Develop and Commercialize KAI-9803 for Cardiovascular Disease |
| May 13 |
Angiotech appoints Hank McKinnell to its Board of Directors |
| May 13 |
Lilly Backs Federal Legislation to Inform the Public on Payments to
Physicians |
| May 14 |
Chronic Medication Nation: Research Finds Chronic Health Problems
Now Afflict More Than Half of All Americans |
| May 14 |
Takeda Completes Subsequent Offering Period for Shares of
Millennium Pharmaceuticals, Inc. |
| May 14 |
Securities Class Action Against Discovery Labs is Dismissed |
| May 14 |
Sosei Announces Outcome of Strategy Review |
| May 14 |
Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets |
| May 14 |
Takeda Completes Acquisition of Millennium |
| May 14 |
FDA Places Geron's GRNOPC1 IND on Clinical Hold |
| May 14 |
FDA releases a Follow-up to the November 14, 2007, Communication
about the Ongoing Safety Review of Cefepime (marketed as Maxipime) |
| May 14 |
Merck Wins Appeal in Vioxx Case |
| May 15 |
Manufacturer Removes Remaining Stocks of Trasylol |
| May 15 |
IMS Health Forecasts Continued Double-Digit Annual Growth of Cancer
Therapeutics: Global Sales Expected to Exceed $75 Billion by 2012 |
| May 15 |
Diabetes Drugs Emerge as Top Force in Drug Spending Growth |
| May 15 |
Biovitrum AB (SE) - Biovitrum Implements Strategic Restructuring of
the R&D Organization |
| May 15 |
Forbes Medi-Tech Announces Corporate Restructuring --Company To
Focus Exclusively on Core Nutraceutical Business and Reduce 2008
Research and Development Expenses by Approximately $2.7 Million- |
| May 15 |
Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized
Distributors and Prescribing Physicians About Stolen Product |
| May 15 |
District Court Decision Affirmed in U.S. Lovenox (enoxaparin
sodium) Patent Infringement Case |
| May 16 |
American Red Cross Vindicated in J&J Lawsuit |
| May 16 |
Statement - New CIHI Report shows value of new medicines in health
care system, Rx&D |
| May 16 |
Antisoma plc (UK) - Antisoma to Acquire Boston-Based Xanthus
Pharmaceuticals |
| May 16 |
Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer
Chemoprevention Trial |
| May 16 |
Biovail Subsidiary Reaches Settlement with United States Department
of Justice |
| May 16 |
Information on Mycophenolate Mofetil (marketed as CellCept) and
Mycophenolic Acid (marketed as Myfortic) |
| May 19 |
Intellect Neurosciences, Inc. Grants License for Certain Patents
and Patent Applications to Wyeth and Elan Pharma International Ltd. |
| May 19 |
Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics
by FDA |
| May 19 |
Biogen Idec Celebrates 30 Years of Transforming Discovery into Care |
| May 19 |
Customs: Commission Publishes 2007 Customs Seizures of Counterfeit
Goods at the EU's External Border |
| May 20 |
Record Venture Capital and Heated Deal Environment Propel Global
Biotechnology Industry Forward in 2007 |
| May 20 |
Global Menopause Summit Concludes HRT is Safe for Healthy Women
Entering Menopause |
| May 20 |
FivePrime and Pfizer Enter Oncology and Diabetes Collaboration |
| May 21 |
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3
Pharma AG |
| May 21 |
ACHIEVE Imaging Study Discontinued |
| May 21 |
Reps. Dingell, Stupak Request Improved Accuracy, Stronger
Guidelines for DTC Ads |
| May 21 |
Lilly Announces Changes in Key Leadership Roles |
| May 22 |
FTC’s Bureau of Competition Issues FY 2007 Summary of
Pharmaceutical Company Settlement Agreements |
| May 22 |
Amgen Posts Medical Education and Foundation Grants and Donations
as Part of the Company's 'Clearly Amgen' Initiative |
| May 22 |
ThalesNano Inc. and sanofi-aventis R&D Collaborate on
Continuous Process Chemistry in Order to Dramatically Reduce Drug
Realization Time |
| May 22 |
AstraZeneca Supports Transparency Legislation on Payments to Health
Care Providers |
| May 22 |
eHealth Initiative's Drug Safety Collaboration to Partner With FDA
on Sentinel Initiative |
| May 22 |
New Efforts to Help Improve Medical Products for Patient Safety and
Quality of Medical Care |
| May 27 |
Migenix Takes Operational Actions To Extend Cash Past Upcoming Key
Milestones |
| May 27 |
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in
RNAi Therapeutics |
| May 27 |
Santarus Achieves $2.5 Million Regulatory Milestone under OTC
License Agreement with Schering-Plough |
| May 27 |
Short-Term Use of Antipsychotics in Older Adults with Dementia
Linked to Serious Adverse Events |
| May 28 |
Taro Terminates Merger Agreement with Sun Pharmaceutical Industries
Ltd. |
| May 28 |
Statement on Third-party Clopidogrel Applications in Germany |
| May 28 |
Pfizer Names Amy W. Schulman as Senior Vice President and General
Counsel |
| May 28 |
Westaim Updates Shareholders on Strategic Alternatives |
| May 28 |
Boston Scientific Announces Court Decision |
| May 28 |
Pharma Companies Integrate Customer Service Portals for Physicians
into the Marketing Mix |
| May 28 |
Australian Full Federal Court Upholds Basic Lipitor Patent,
Preventing Launch of Generic Ranbaxy Product |
| May 28 |
Schweizerhall: Clopidogrel From Cimex Approved in Germany |
| May 29 |
Favrille Announces Workforce Reduction |
| May 29 |
Sun Pharma responds to Taro's purported termination of merger
agreement |
| May 29 |
Bristol-Myers Squibb to Acquire Kosan Biosciences |
| May 29 |
Merck Wins Appeal of First Vioxx Case to Go to Trial |
| May 29 |
Merck Wins Appeal of First Vioxx Case to go to Trial |
| May 29 |
Cardiovascular Meds May Be Beneficial in Alzheimer's Disease,
According to MedPredict Report |
| May 29 |
Assembly on the Move for Rx Reform |
| May 29 |
The Lanier Law Firm Will Appeal Court Reversal of Jury Award to
Widow in Nation's 1st Vioxx Trial |
| May 30 |
Gilead and Navitas Announce Agreement for Cicletanine for the
Treatment of Pulmonary Arterial Hypertension |
| May 30 |
Bristol-Myers Squibb Reaffirms 2008 Earnings Guidance |
| May 30 |
Pharmacopeia Advances Strategic Plan to Focus Resources on
Development and Later-Stage Discovery Programs |
